Geode Capital Management’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $376M | Sell |
710,465
-34,641
| -5% | -$16M | 0.02% | 552 |
|
|
2026
Q1 | $358M | Buy |
745,106
+77,808
| +12% | +$39.8M | 0.02% | 539 |
|
|
2025
Q4 | $375M | Buy |
667,298
+24,625
| +4% | +$14M | 0.02% | 519 |
|
|
2025
Q3 | $330M | Buy |
642,673
+4,746
| +0.7% | +$2.07M | 0.02% | 528 |
|
|
2025
Q2 | $200M | Sell |
637,927
-30,276
| -5% | -$9.09M | 0.01% | 665 |
|
|
2025
Q1 | $204M | Buy |
668,203
+12,073
| +2% | +$4.06M | 0.02% | 637 |
|
|
2024
Q4 | $218M | Buy |
656,130
+28,076
| +4% | +$9.52M | 0.02% | 606 |
|
|
2024
Q3 | $210M | Buy |
628,054
+44,371
| +8% | +$16.9M | 0.02% | 618 |
|
|
2024
Q2 | $241M | Buy |
583,683
+50,934
| +10% | +$20.2M | 0.02% | 536 |
|
|
2024
Q1 | $215M | Buy |
532,749
+39,818
| +8% | +$14M | 0.02% | 571 |
|
|
2023
Q4 | $151M | Buy |
492,931
+7,297
| +2% | +$1.97M | 0.02% | 651 |
|
|
2023
Q3 | $118M | Buy |
485,634
+7,888
| +2% | +$2.02M | 0.01% | 700 |
|
|
2023
Q2 | $115M | Sell |
477,746
-110,198
| -19% | -$22.9M | 0.01% | 711 |
|
|
2023
Q1 | $111M | Buy |
587,944
+2,129
| +0.4% | +$440K | 0.01% | 694 |
|
|
2022
Q4 | $124M | Buy |
585,815
+51,462
| +10% | +$10.3M | 0.02% | 627 |
|
|
2022
Q3 | $84M | Sell |
534,353
-29,348
| -5% | -$4.68M | 0.01% | 752 |
|
|
2022
Q2 | $84.4M | Buy |
563,701
+19,343
| +4% | +$2.8M | 0.01% | 773 |
|
|
2022
Q1 | $89.1M | Buy |
544,358
+7,605
| +1% | +$1.25M | 0.01% | 850 |
|
|
2021
Q4 | $117M | Buy |
536,753
+9,686
| +2% | +$2.03M | 0.01% | 743 |
|
|
2021
Q3 | $99.8M | Buy |
527,067
+5,845
| +1% | +$1.07M | 0.01% | 799 |
|
|
2021
Q2 | $92.1M | Buy |
521,222
+24,763
| +5% | +$4.27M | 0.01% | 837 |
|
|
2021
Q1 | $81.4M | Buy |
496,459
+37,040
| +8% | +$5.67M | 0.01% | 885 |
|
|
2020
Q4 | $64M | Buy |
459,419
+16,982
| +4% | +$2.14M | 0.01% | 943 |
|
|
2020
Q3 | $49.4M | Sell |
442,437
-2,254
| -0.5% | -$261K | 0.01% | 917 |
|
|
2020
Q2 | $41.4M | Sell |
444,691
-6,232
| -1% | -$530K | 0.01% | 996 |
|
|
2020
Q1 | $33.1M | Buy |
450,923
+23,691
| +6% | +$2.06M | 0.01% | 977 |
|
|
2019
Q4 | $35.9M | Buy |
427,232
+4,306
| +1% | +$333K | 0.01% | 1161 |
|
|
2019
Q3 | $35.5M | Buy |
422,926
+21,192
| +5% | +$1.6M | 0.01% | 1088 |
|
|
2019
Q2 | $26.3M | Buy |
401,734
+49,117
| +14% | +$2.83M | 0.01% | 1300 |
|
|
2019
Q1 | $20.8M | Buy |
352,617
+31,679
| +10% | +$1.89M | 0.01% | 1394 |
|
|
2018
Q4 | $17M | Buy |
320,938
+16,521
| +5% | +$907K | 0.01% | 1397 |
|
|
2018
Q3 | $18.2M | Buy |
304,417
+114,945
| +61% | +$6.29M | 0.01% | 1479 |
|
|
2018
Q2 | $8.15M | Buy |
189,472
+51,173
| +37% | +$2.07M | ﹤0.01% | 2038 |
|
|
2018
Q1 | $4.83M | Buy |
138,299
+21,087
| +18% | +$770K | ﹤0.01% | 2257 |
|
|
2017
Q4 | $4.25M | Buy |
117,212
+15,570
| +15% | +$546K | ﹤0.01% | 2304 |
|
|
2017
Q3 | $3.24M | Buy |
101,642
+8,195
| +9% | +$250K | ﹤0.01% | 2463 |
|
|
2017
Q2 | $2.71M | Buy |
93,447
+7,723
| +9% | +$217K | ﹤0.01% | 2551 |
|
|
2017
Q1 | $2.56M | Buy |
85,724
+4,929
| +6% | +$159K | ﹤0.01% | 2515 |
|
|
2016
Q4 | $2.91M | Buy |
80,795
+11,576
| +17% | +$386K | ﹤0.01% | 2411 |
|
|
2016
Q3 | $2.07M | Buy |
+69,219
| New | +$2.02M | ﹤0.01% | 2540 |
|
Other funds holding MEDP
WA
Geode Capital Management's MEDP Position: Q2 2026 in Review
Geode Capital Management reduced its Medpace (MEDP) stake by 4.6% in Q2 2026, selling an estimated $16M and leaving 710,465 shares worth $376M. The position accounts for 0.02% of the portfolio, ranked #552.
Geode Capital Management first reported a position in MEDP in Q3 2016 and has held it in 40 quarters since. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- Geode Capital Management held 710,465 shares of Medpace worth $376M as of Q2 2026.
- Geode Capital Management sold 34,641 Medpace shares in Q2 2026, an estimated $16M.
- Medpace made up 0.02% of Geode Capital Management's portfolio in Q2 2026, its #552 holding.
- Geode Capital Management first reported a position in Medpace in Q3 2016 and has held it in 40 quarters since.
- 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.